Jazz Pharmaceuticals
JAZZ
JAZZ
436 hedge funds and large institutions have $8.73B invested in Jazz Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 81 funds opening new positions, 131 increasing their positions, 172 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 389 → 436 (+47)
3.68% less ownership
Funds ownership: 98.29% → 94.61% (-3.7%)
24% less repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 172
Holders
436
Holding in Top 10
8
Calls
$115M
Puts
$78.8M
Top Buyers
| 1 | +$44.7M | |
| 2 | +$35.1M | |
| 3 | +$32.2M | |
| 4 |
Jennison Associates
New York
|
+$29.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$25.8M |
Top Sellers
| 1 | -$78.9M | |
| 2 | -$67.2M | |
| 3 | -$46.5M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$43.3M |
| 5 |
Renaissance Technologies
New York
|
-$35.1M |